Mortality following a brain tumour diagnosis in patients with multiple sclerosis

BMJ Open

Volumn 3, Issue 11, 2013, Pages

  Montgomery, Scott ^a,b,c   Hassan, Ahmad ^b   Bahmanyar, Shahram ^c,d   Brus, Ole ^a   Hussein, Oula ^a   Hiyoshi, Ayako ^a   Hillert, Jan ^e   Olsson, Tomas ^e   Fall, Katja ^a,b  

^a ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^b ÖREBRO UNIVERSITY   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d GOLESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ASTROCYTOMA; BRAIN TUMOR; CHOLESTEATOMA; CONTROLLED STUDY; CRANIOPHARYNGIOMA; EPENDYMOBLASTOMA; EPENDYMOMA; FEMALE; GERM CELL TUMOR; HAMARTOMA; HEMANGIOBLASTOMA; HEMANGIOMA; HEMANGIOPERICYTOMA; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDULLOBLASTOMA; MENINGIOMA; MORTALITY; MULTIPLE SCLEROSIS; NEURILEMOMA; NEUROBLASTOMA; NEUROFIBROMA; POPULATION; SWEDEN; TERATOMA; TUMOR DIAGNOSIS;

EID: 84888090255     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2013-003622     Document Type: Article

References (12)

1. Bahmanyar S, Montgomery SM, Hillert J, et al. Cancer risk among patients with multiple sclerosis and their parents. Neurology 2009;72:1170-7.
2. Hofer S, Linnebank M, Weller M, et al. Correspondence: cancer risk among patients with multiple sclerosis and their parents. Neurology 2010;74:614-15.
3. National Board of Health and Welfare. The Swedish Hospital Discharge Register 1987-1996: Quality and Contents. Stockholm: Centre for Epidemiology, 1998. http://www.socialstyrelsen. se/Lists/Artikelkatalog/Attachments/8708/2008- 125-1-20081251-rev.pdf (accessed 27 Sep. 2013).
4. Andersen O. From the Gothenburg cohort to the Swedish multiple sclerosis registry. Acta Neurol Scand Suppl 2012;126:13-19.
5. Mattsson B, Wallgren A. Completeness of the Swedish Cancer Register. Non-notified cancer cases recorded on death certificates in 1978. Acta Radiol Oncol 1984;23:305-13. (Pubitemid 15028463)
6. Andersson A, Persson PM, Fredrikson S. Place of residence determines access to interferon-beta therapy in MS. Less than 15 per cent of patients are treated-big differences between the counties. Lakartidningen 1999;96:5492-5.
7. Montgomery S, Hillert J, Bahmanyar S. Hospital admission due to infections in multiple sclerosis patients. Eur J Neurol 2013;20:1153-60.
8. Jadidi E, Mohammadi M, Moradi T. High risk of cardiovascular diseases after diagnosis of multiple sclerosis. Multiple Scleroris 2013;19:1336-40.
9. Hirst C, Swingler R, Compston D A S, et al. Survival and cause of death in multiple sclerosis: a prospective population-based study. J Neurol Neurosurg Psychiatry 2008;79:1016-21.
10. Koch-Henriksen N, Bronnum-Hansen H, Stenager E. Underlying cause of death in Danish patients with multiple sclerosis: results from the Danish Multiple Sclerosis Registry. J Neurol Neurosurg Psychiatry 1998;65:56-9. (Pubitemid 28302357)
11. Ragonese P, Aridon P, Salemi G, et al. Mortality in multiple sclerosis: a review. Eur J Neurol 2008;15:123-7.
12. Scalfari A, Knappertz V, Cutter G, et al. Mortality in patients with multiple sclerosis. Neurology 2013;81:184-92.